1
|
Llamas-Molina JM, Carrero-Castaño A, Ruiz-Villaverde R, Campos A. Tissue Engineering and Regeneration of the Human Hair Follicle in Androgenetic Alopecia: Literature Review. Life (Basel) 2022; 12:117. [PMID: 35054510 PMCID: PMC8779163 DOI: 10.3390/life12010117] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2021] [Revised: 01/05/2022] [Accepted: 01/08/2022] [Indexed: 12/26/2022] Open
Abstract
Androgenetic alopecia (AGA) is an androgen-dependent process and represents the most frequent non-scarring alopecia. Treatments for AGA do not always achieve a satisfactory result for the patient, and sometimes cause side effects that lead to discontinuation of treatment. AGA therapeutics currently includes topical and oral drugs, as well as follicular unit micro-transplantation techniques. Tissue engineering (TE) is postulated as one of the possible future solutions to the problem and aims to develop fully functional hair follicles that maintain their cyclic rhythm in a physiological manner. However, despite its great potential, reconstitution of fully functional hair follicles is still a challenge to overcome and the knowledge gained of the key processes in hair follicle morphogenesis and biology has not yet been translated into effective replacement therapies in clinical practice. To achieve this, it is necessary to research and develop new approaches, techniques and biomaterials. In this review, present and emerging hair follicle bioengineering strategies are evaluated. The current problems of these bioengineering techniques are discussed, as well as the advantages and disadvantages, and the future prospects for the field of TE and successful hair follicle regeneration.
Collapse
Affiliation(s)
| | | | - Ricardo Ruiz-Villaverde
- Department of Dermatology, Hospital Universitario San Cecilio, 18016 Granada, Spain;
- Instituto Biosanitario de Granada, Ibs, 18016 Granada, Spain;
| | - Antonio Campos
- Instituto Biosanitario de Granada, Ibs, 18016 Granada, Spain;
- Tissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, 18016 Granada, Spain
| |
Collapse
|
2
|
Lu K, Han Q, Ma Z, Yan Q, Pei Y, Shi P, Zhang J, Rong K, Ma K, Li P, Hou T. Injectable platelet rich fibrin facilitates hair follicle regeneration by promoting human dermal papilla cell proliferation, migration, and trichogenic inductivity. Exp Cell Res 2021; 409:112888. [PMID: 34715152 DOI: 10.1016/j.yexcr.2021.112888] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2021] [Revised: 10/14/2021] [Accepted: 10/18/2021] [Indexed: 11/30/2022]
Abstract
Hair follicle regeneration has been successful in mice but failed in human being for years. Dermal papilla cells, a specialized mesenchymal stem cell derived from dermal papilla within hair follicles, is considered the key cells for hair follicle regeneration function as both regeneration initiator and regulator. Injectable platelet rich fibrin (i-PRF), a novel biomaterial rich in a variety of growth factors and three-dimensional scaffolds, has shown promising effects on tissue regeneration. In this study, we aimed to evaluate the application of i-PRF in human hair follicle regeneration by examining the biological effects of i-PRF on human dermal papilla cells (hDPCs). Biomaterial compatibility, cell viability, proliferation, migration, alkaline phosphatase activity and trichogenic inductivity were assessed after exposing hDPCs to different concentrations of i-PRF extracts. In addition, we investigated the ultrastructure of i-PRF with all cell components filtered. The results revealed that i-PRF possessing excellent biocompatibility and could significantly promote hDPCs proliferation, migration, and trichogenic inductivity. Furthermore, the concentration of i-PRF is able to remarkably influence hDPCs behavior in a dose-dependent pattern. Different concentrations exhibited differential effects on hDPCs behavior. In general, lower concentration promotes cell proliferation better than higher concentration, while higher concentration promotes cell function better reversely. Best concentration for hDPCs in vitro expending is 1% concentration. 20% concentration is optimal for hair follicle regeneration. In summary, our findings concluded that i-PRF facilitates hair follicle regeneration by promoting human dermal papilla cell proliferation, migration, and trichogenic inductivity.
Collapse
Affiliation(s)
- Kongye Lu
- Dalian Medical University, Dalian, Liaoning, 116000, China; The Yangzhou School of Clinical Medicine of Dalian Medical University, Yangzhou, Jiangsu, 225000, China.
| | - Qiwen Han
- Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, 225000, China.
| | - Zekun Ma
- Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, 225000, China.
| | - Qingqing Yan
- Dalian Medical University, Dalian, Liaoning, 116000, China; The Yangzhou School of Clinical Medicine of Dalian Medical University, Yangzhou, Jiangsu, 225000, China.
| | - Yunlong Pei
- Dalian Medical University, Dalian, Liaoning, 116000, China; The Yangzhou School of Clinical Medicine of Dalian Medical University, Yangzhou, Jiangsu, 225000, China.
| | - Pengzhi Shi
- Dalian Medical University, Dalian, Liaoning, 116000, China; The Yangzhou School of Clinical Medicine of Dalian Medical University, Yangzhou, Jiangsu, 225000, China.
| | - Jin Zhang
- I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
| | - Kunjie Rong
- Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, 225000, China.
| | - Kun Ma
- Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, 225000, China.
| | - Pingsong Li
- The Yangzhou School of Clinical Medicine of Dalian Medical University, Yangzhou, Jiangsu, 225000, China; Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, 225000, China.
| | - Tuanjie Hou
- The Yangzhou School of Clinical Medicine of Dalian Medical University, Yangzhou, Jiangsu, 225000, China; Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, 225000, China.
| |
Collapse
|